These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1358038)

  • 21. Conventional DMARD therapy (methotrexate-sulphasalazine) may decrease the requirement of biologics in routine practice of ankylosing spondylitis patients: a real-life experience.
    Can M; Aydın SZ; Niğdelioğlu A; Atagündüz P; Direskeneli H
    Int J Rheum Dis; 2012 Dec; 15(6):526-30. PubMed ID: 23253235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double blind comparative study of sulphasalazine and hydroxychloroquine in rheumatoid arthritis: evidence of an earlier effect of sulphasalazine.
    Nuver-Zwart IH; van Riel PL; van de Putte LB; Gribnau FW
    Ann Rheum Dis; 1989 May; 48(5):389-95. PubMed ID: 2567150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treating rheumatoid arthritis early with disease modifying drugs reduces joint damage: a randomised double blind trial of sulphasalazine vs diclofenac sodium.
    Choy EH; Scott DL; Kingsley GH; Williams P; Wojtulewski J; Papasavvas G; Henderson E; Macfarlane D; Erhardt C; Young A; Plant MJ; Panayi GS
    Clin Exp Rheumatol; 2002; 20(3):351-8. PubMed ID: 12102471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective trial comparing the use of sulphasalazine and auranofin as second line drugs in patients with rheumatoid arthritis.
    Porter D; Madhok R; Hunter JA; Capell HA
    Ann Rheum Dis; 1992 Apr; 51(4):461-4. PubMed ID: 1350192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sulphasalazine-induced lupus in psoriatic arthritis.
    Veale DJ; Ho M; Morley KD
    Br J Rheumatol; 1995 Apr; 34(4):383-4. PubMed ID: 7788157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of ocular cicatricial pemphigoid with sulfasalazine].
    Le Rouic JF; Robin H; Doan S; Prisant O; Belayachi N; Hoang-Xuan T
    J Fr Ophtalmol; 1999 May; 22(4):423-5. PubMed ID: 10365328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of sulphasalazine plus methotrexate in rheumatoid arthritis.
    Islam MN; Alam MN; Haq SA; Moyenuzzaman M; Patwary MI; Rahman MH
    Bangladesh Med Res Counc Bull; 2000 Apr; 26(1):1-7. PubMed ID: 11192489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spondyloarthritides in females.
    Gran JT; Ostensen M
    Baillieres Clin Rheumatol; 1998 Nov; 12(4):695-715. PubMed ID: 9928503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Why is the concept of spondyloarthropathies important?
    Dougados M; Hochberg MC
    Best Pract Res Clin Rheumatol; 2002 Sep; 16(4):495-505. PubMed ID: 12406423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ankylosing spondylitis. Current drug treatment.
    Gran JT; Husby G
    Drugs; 1992 Oct; 44(4):585-603. PubMed ID: 1281074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of sulphasalazine as a disease modifying antirheumatic drug.
    Porter DR; Capell HA
    Baillieres Clin Rheumatol; 1990 Dec; 4(3):535-51. PubMed ID: 1982707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sulphasalazine in the treatment of juvenile rheumatoid arthritis: a preliminary open trial.
    Ozdogan H; Turunç M; Deringöl B; Yurdakul S; Yazici H
    J Rheumatol; 1986 Feb; 13(1):124-5. PubMed ID: 2871188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Desensitization to sulphasalazine in patients with arthritis.
    Koski JM
    Clin Exp Rheumatol; 1993; 11(2):169-70. PubMed ID: 8099541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Sulfasalazine in rheumatoid arthritis].
    Segal R; Caspi D; Sukenik S; Horowitz I; Rubinov A; Fluser D; Scharf Y; Shapira D; Weinberger A; Gedz D
    Harefuah; 1991 May; 120(10):577-81. PubMed ID: 1682225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sulphasalazine: a safe, effective agent for prolonged control of rheumatoid arthritis. A comparison with sodium aurothiomalate.
    Bax DE; Amos RS
    Ann Rheum Dis; 1985 Mar; 44(3):194-8. PubMed ID: 2858182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognosis, course of disease, and treatment of the spondyloarthropathies.
    Leirisalo-Repo M
    Rheum Dis Clin North Am; 1998 Nov; 24(4):737-51, viii. PubMed ID: 9891708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hydroxychloroquine and sulphasalazine alone and in combination in rheumatoid arthritis: a randomised double blind trial.
    Faarvang KL; Egsmose C; Kryger P; Pødenphant J; Ingeman-Nielsen M; Hansen TM
    Ann Rheum Dis; 1993 Oct; 52(10):711-5. PubMed ID: 7903034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sulphasalazine in the long term management of rheumatoid arthritis.
    Bax DE; Amos RS
    Drugs; 1986; 32 Suppl 1():73-6. PubMed ID: 2877858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rheumatoid arthritis: a risk factor for sulphasalazine toxicity? A meta-analysis.
    Wijnands MJ; Van 'T Hof MA; Van De Putte LB; Van Riel PL
    Br J Rheumatol; 1993 Apr; 32(4):313-8. PubMed ID: 8096419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sulfasalazine therapy in psoriatic arthritis: clinical and immunologic response.
    Newman ED; Perruquet JL; Harrington TM
    J Rheumatol; 1991 Sep; 18(9):1379-82. PubMed ID: 1684619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.